In vitro oxygen imaging of acellular and cell-loaded beta cell replacement devices

Type 1 diabetes (T1D) is an autoimmune disease that leads to the loss of insulin-producing beta cells. Bioartificial pancreas (BAP) or beta cell replacement strategies have shown promise in curing T1D and providing long-term insulin independence. Hypoxia (low oxygen concentration) that may occur in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotecha, Mrignayani, Wang, Longhai, Hameed, Safa, Viswakarma, Navin, Ma, Minglin, Stabler, Cherie, Hoesli, Corinne A., Epel, Boris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511476/
https://www.ncbi.nlm.nih.gov/pubmed/37730815
http://dx.doi.org/10.1038/s41598-023-42099-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511476/
https://www.ncbi.nlm.nih.gov/pubmed/37730815
http://dx.doi.org/10.1038/s41598-023-42099-w

Ejemplares similares